Enantioselective and Nonlinear Intestinal Absorption of Eflornithine in the Rat
- 1 August 2008
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (8) , 2842-2848
Abstract
This study aimed to investigate if the absorption of the human African trypanosomiasis agent eflornithine was stereospecific and dose dependent after oral administration. Male Sprague-Dawley rats were administered single doses of racemic eflornithine hydrochloride as an oral solution (750, 1,500, 2,000, or 3,000 mg/kg of body weight) or intravenously (375 or 1,000 mg/kg of body weight). Sparse blood samples were obtained for determination of eflornithine enantiomers by liquid chromatography with evaporative light-scattering detection (lower limit of quantification [LLOQ], 83 μM for 300 μl plasma). The full plasma concentration-time profile of racemic eflornithine following frequent sampling was determined for another group of rats, using a high-performance liquid chromatography-UV method (LLOQ, 5 μM for 50 μl plasma). Pharmacokinetic data were analyzed in NONMEM for the combined racemic and enantiomeric concentrations. Upon intravenous administration, the plasma concentration-time profile of eflornithine was biphasic, with marginal differences in enantiomer kinetics (mean clearances of 14.5 and 12.6 ml/min/kg forl- andd-eflornithine, respectively). The complex absorption kinetics were modeled with a number of transit compartments to account for delayed absorption, transferring the drug into an absorption compartment from which the rate of influx was saturable. The mean bioavailabilities forl- andd-eflornithine were 41% and 62%, respectively, in the dose range of 750 to 2,000 mg/kg of body weight, with suggested increases to 47% and 83%, respectively, after a dose of 3,000 mg/kg of body weight. Eflornithine exhibited enantioselective absorption, with the more potentl-isomer being less favored, a finding which may help to explain why clinical attempts to develop an oral treatment have hitherto failed. The mechanistic explanation for the stereoselective absorption remains unclear.Keywords
This publication has 20 references indexed in Scilit:
- Human African trypanosomiasis: pharmacological re‐engagement with a neglected diseaseBritish Journal of Pharmacology, 2007
- Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studiesJournal of Pharmacokinetics and Pharmacodynamics, 2007
- Determination of eflornithine enantiomers in plasma, by solid-phase extraction and liquid chromatography with evaporative light-scattering detectionJournal of Chromatography B, 2007
- Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of Congo2006
- Pharmacokinetics of Desmopressin Administrated as an Oral Lyophilisate Dosage Form in Children With Primary Nocturnal Enuresis and Healthy AdultsThe Journal of Clinical Pharmacology, 2006
- Human African trypanosomiasisNeurology, 2006
- Drug‐resistance of Trypanosoma b. rhodesiense isolates from TanzaniaTropical Medicine & International Health, 2006
- The pharmacokinetics of eflornithine (?-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sicknessEuropean Journal of Clinical Pharmacology, 2004
- Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithineBiochemical Journal, 2003
- Assay of α-difluoromethylornithine in body fluids and tissues by automatic amino-acid analysisJournal of Chromatography B: Biomedical Sciences and Applications, 1981